Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

245.11
Delayed Data
As of Feb 11
 -7.09 / -2.81%
Today’s Change
243.03
Today|||52-Week Range
480.18
-19.99%
Year-to-Date

Today’s Trading

Previous close252.20
Today’s open246.31
Day’s range243.03 - 250.02
Volume2,171,180
Average volume (3 months)2,353,947
Market cap$55.1B
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+9.52%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.01%
P/E ratio16.0
Price/Sales6.58
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-0.44-1.17%
BAXBaxter International...-1.03-2.79%
XONIntrexon Corp-0.80-2.56%
JUNOJuno Therapeutics In...+0.89+3.37%
Data as of 02/11/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$4.46
Annual revenue (last year)$10.8B
Annual profit (last year)$3.5B
Net profit margin32.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Senior Medical Director
Diego Cadavid
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers